Dr Nick Pavlakis underwent medical training at the University of NSW and graduated in 1991. He underwent general medical training and subsequent advanced training in Medical Oncology at Royal North Shore Hospital, completing FRACP in 1997. He then spent 3 years completing a PhD in new cancer drug development and a Masters of Clinical Epidemiology through the University of Sydney. He has been on staff in the Department of Medical Oncology at Royal North Shore Hospital since 2001 and has been Head of Department and Head of the Clinical Trials Unit since 2008. He has worked in private oncology practice since 1998 and a practice member of the Northern Cancer Institute since 2001. He has previously served on the Executive of the Medical Oncology Group of Australia (MOGA), the Private Cancer Physicians Group of Australia (PCPA), the Australian Lung Cancer Trials Group and on Advisory boards for colorectal and lung cancers and new cancer drugs.
He is an academic medical oncologist, having published numerous journal manuscripts, is conducting ongoing research and teaching activities locally through RNSH and NCI (University of Sydney) and externally (through MOGA, PCPA, RACP).
His clinical interest is in solid tumour oncology, particularly lung cancers, mesothelioma, colorectal cancer, all other gastrointestinal cancers and genitourinary cancers (prostate, kidney, and testis). His clinical research focuses on trials in these tumour types and includes new cancer drug development, especially in the area of anti-angiogenesis drugs.
Dr Pavlakis is a VMO at North Shore Private Hospital, the Mater Misericordiae Hospital, Dalcross Hospital and Armidale Hospital.